These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32006624)

  • 21. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
    Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
    Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of ketoprofen dissolution rate by the liquisolid technique: optimization and in vitro and in vivo investigations.
    Devi S; Kumar S; Verma V; Kaushik D; Verma R; Bhatia M
    Drug Deliv Transl Res; 2022 Nov; 12(11):2693-2707. PubMed ID: 35178670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
    Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
    J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
    Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
    Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of griseofulvin release from liquisolid compacts.
    Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
    Eur J Pharm Biopharm; 2012 Jan; 80(1):130-5. PubMed ID: 21846502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of solid carriers in pharmaceutical performance of solid supersaturable SEDDS of celecoxib.
    Chavan RB; Modi SR; Bansal AK
    Int J Pharm; 2015 Nov; 495(1):374-384. PubMed ID: 26364711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation Development of Mirtazapine Liquisolid Compacts: Optimization Using Central Composite Design.
    Naureen F; Shah Y; Shah SI; Abbas M; Rehman IU; Muhammad S; Hamdullah H; Goh KW; Khuda F; Khan A; Chan SY; Mushtaq M; Ming LC
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
    Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F
    Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique.
    Tayel SA; Soliman II; Louis D
    Eur J Pharm Biopharm; 2008 May; 69(1):342-7. PubMed ID: 17949959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
    Pattnaik S; Pathak K
    Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug loading into porous calcium carbonate microparticles by solvent evaporation.
    Preisig D; Haid D; Varum FJ; Bravo R; Alles R; Huwyler J; Puchkov M
    Eur J Pharm Biopharm; 2014 Aug; 87(3):548-58. PubMed ID: 24568926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug release from liquisolid systems: speed it up, slow it down.
    Nokhodchi A; Hentzschel CM; Leopold CS
    Expert Opin Drug Deliv; 2011 Feb; 8(2):191-205. PubMed ID: 21222556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suitability of various excipients as carrier and coating materials for liquisolid compacts.
    Hentzschel CM; Sakmann A; Leopold CS
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1200-7. PubMed ID: 21449826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquisolid systems: Understanding the impact of drug state (solution or dispersion), nonvolatile solvent and coating material on simvastatin apparent aqueous solubility and flowability.
    Anzilaggo D; O'Reilly Beringhs A; Pezzini BR; Sonaglio D; Stulzer HK
    Colloids Surf B Biointerfaces; 2019 Mar; 175():36-43. PubMed ID: 30517903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Approach to Enhance Dissolution Rate of Tamoxifen Citrate.
    SreeHarsha N; Hiremath JG; Chilukuri S; Aitha RK; Al-Dhubiab BE; Venugopala KN; Alzahrani AM; Meravanige G
    Biomed Res Int; 2019; 2019():2161348. PubMed ID: 30800663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loading amorphous Asarone in mesoporous silica SBA-15 through supercritical carbon dioxide technology to enhance dissolution and bioavailability.
    Zhang Z; Quan G; Wu Q; Zhou C; Li F; Bai X; Li G; Pan X; Wu C
    Eur J Pharm Biopharm; 2015 May; 92():28-31. PubMed ID: 25720818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solid lipid nanoparticles for encapsulation of hydrophilic drugs by an organic solvent free double emulsion technique.
    Becker Peres L; Becker Peres L; de Araújo PHH; Sayer C
    Colloids Surf B Biointerfaces; 2016 Apr; 140():317-323. PubMed ID: 26764112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesoporous silica formulation strategies for drug dissolution enhancement: a review.
    McCarthy CA; Ahern RJ; Dontireddy R; Ryan KB; Crean AM
    Expert Opin Drug Deliv; 2016; 13(1):93-108. PubMed ID: 26549623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.